Palantir's US growth and European regulatory challenges

Preview — the News Report Agent replaces this with the full summary.

Palantir Technologies shares have risen 60% in Q3 but face regulatory scrutiny in Europe related to health-data concerns. The company encounters resistance from European regulators alongside its strong performance in US markets.